These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21257227)

  • 1. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
    Quelhas D; Jiménez A; Quintó L; Serra-Casas E; Mayor A; Cisteró P; Puyol L; Wilson DW; Richards JS; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Aponte JJ; Alonso PL; Beeson JG; Menéndez C; Dobaño C
    Immunobiology; 2011 Jul; 216(7):793-802. PubMed ID: 21257227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Dorman EK; Kawuondo K; Marsh K; Hviid L
    Infect Immun; 2004 Sep; 72(9):5027-30. PubMed ID: 15321995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Aubouy A; Migot-Nabias F; Deloron P
    Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment.
    Aitken EH; Mbewe B; Luntamo M; Maleta K; Kulmala T; Friso MJ; Fowkes FJ; Beeson JG; Ashorn P; Rogerson SJ
    J Infect Dis; 2010 May; 201(9):1316-25. PubMed ID: 20350189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.
    Quelhas D; Puyol L; Quintó L; Serra-Casas E; Nhampossa T; Macete E; Aide P; Mayor A; Mandomando I; Sanz S; Aponte JJ; Chauhan VS; Chitnis CE; Alonso PL; Menéndez C; Dobaño C
    Clin Vaccine Immunol; 2008 Aug; 15(8):1282-91. PubMed ID: 18495848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
    Schreiber N; Kobbe R; Adjei S; Adjei O; Klinkert MQ; May J
    Trop Med Int Health; 2007 Oct; 12(10):1157-63. PubMed ID: 17956497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
    J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].
    Diouf I; Tine RC; Ndiaye JL; Sylla K; Faye B; Mengue ML; Faye O; Dieng Y; Gaye A; Gaye O
    Bull Soc Pathol Exot; 2011 Oct; 104(4):277-83. PubMed ID: 21818679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults.
    Elliott SR; Payne PD; Duffy MF; Byrne TJ; Tham WH; Rogerson SJ; Brown GV; Eisen DP
    Am J Trop Med Hyg; 2007 May; 76(5):860-4. PubMed ID: 17488905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.
    Yone CL; Kremsner PG; Luty AJ
    Infect Immun; 2005 Apr; 73(4):2281-7. PubMed ID: 15784572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
    Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
    J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
    Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
    Kinyanjui SM; Mwangi T; Bull PC; Newbold CI; Marsh K
    J Infect Dis; 2004 Nov; 190(9):1527-33. PubMed ID: 15478055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.
    Nhabomba AJ; Guinovart C; Jiménez A; Manaca MN; Quintó L; Cisteró P; Aguilar R; Barbosa A; Rodríguez MH; Bassat Q; Aponte JJ; Mayor A; Chitnis CE; Alonso PL; Dobaño C
    Malar J; 2014 Mar; 13():121. PubMed ID: 24674654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.
    Mount AM; Mwapasa V; Elliott SR; Beeson JG; Tadesse E; Lema VM; Molyneux ME; Meshnick SR; Rogerson SJ
    Lancet; 2004 Jun; 363(9424):1860-7. PubMed ID: 15183624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.
    Fievet N; Le Hesran JY; Cottrell G; Doucoure S; Diouf I; Ndiaye JL; Bertin G; Gaye O; Sow S; Deloron P
    Infect Genet Evol; 2006 Nov; 6(6):459-63. PubMed ID: 16621725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.